NCT00169962View on ClinicalTrials.gov

Study of Pulmozyme to Treat Severe Asthma Episodes

PHASE2CompletedINTERVENTIONAL

Enrollment

51

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions

Asthma

Interventions

DRUG

rhDNAse (pulmozyme)

Trial Locations (1)

11040

LIJMC, Queens

Sponsors

Lead Sponsor

Northwell Health

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

Northwell Health

OTHER